SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-025623
Filing Date
2022-02-22
Accepted
2022-02-22 16:10:51
Documents
13
Period of Report
2022-02-22
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm227153d1_8k.htm   iXBRL 8-K 27817
2 EXHIBIT 99.1 tm227153d1_ex99-1.htm EX-99.1 15996
  Complete submission text file 0001104659-22-025623.txt   222671

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rzlt-20220222.xsd EX-101.SCH 3042
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rzlt-20220222_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rzlt-20220222_pre.xml EX-101.PRE 22601
7 EXTRACTED XBRL INSTANCE DOCUMENT tm227153d1_8k_htm.xml XML 3605
Mailing Address 201 REDWOOD SHORES PARKWAY, SUITE 315 REDWOOD CITY CA 94065
Business Address 201 REDWOOD SHORES PARKWAY, SUITE 315 REDWOOD CITY CA 94065 650-847-1919
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39683 | Film No.: 22658148
SIC: 2834 Pharmaceutical Preparations